From the 4C Quarterly -
“Several new products addressing growing market needs, including supplements and topical lotions, have been formulated during FY2021 with launch expected in the coming months.“ (page 2)
"“The Company’s first hair loss supplement is currently being manufactured and an ecommerce launch is on track for 1H FY2022. " (page 3)
poorinvestor
- Forums
- ASX - By Stock
- Ann: Appendix 4E and FY21 Financial Report
From the 4C Quarterly -“Several new products addressing growing...
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online